NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD is a registered legal entity registered in Singapore under 199703791E, and its current status with Accounting and Corporate Regulatory Authority (ACRA) is active. The company was incorporated on 6 December 1996 and lists its registered address as SINGAPORE, Singapore. 1 shareholder is on record for NOVO NORDISK PHARMA (SINGAPORE) PTE LTD, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Accounting and Corporate Regulatory Authority (ACRA) and was last updated on 6 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for NOVO NORDISK PHARMA (SINGAPORE) PTE LTD, held on the electronic register of members filed via BizFile, filed under the Companies Act 1967.
The largest of these is NOVO NORDISK REGION AAMEO AND LATAM A/S, holding 100% — a majority holding.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| NOVO NORDISK REGION AAMEO AND LATAM A/S | 100% | Accounting and Corporate Regulatory Authority (ACRA) |
Officers
41
The Director of NOVO NORDISK PHARMA (SINGAPORE) PTE LTD currently on record is ANANDA SHETTY; six of the 41 officer records shown for NOVO NORDISK PHARMA (SINGAPORE) PTE LTD are current appointments, filed with Accounting and Corporate Regulatory Authority (ACRA). The remaining 34 records shown (HENRIK EKELUND, GAN CHENG and 28 others) are former appointments that have since been resigned.
Management authority at NOVO NORDISK PHARMA (SINGAPORE) PTE LTD sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD sits 4 levels below its ultimate parent, Novo Nordisk Fonden, registered in Denmark. Immediately above NOVO NORDISK PHARMA (SINGAPORE) PTE LTD is Novo Nordisk Region Aameo And Latam A/S, holding 100% as filed in NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's own shareholder record with Accounting and Corporate Regulatory Authority (ACRA). Novo Nordisk Fonden sits further up the chain, a link derived by walking shareholder filings across jurisdictions rather than stated in a single document.
Novo Nordisk Fonden
Denmark
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns NOVO NORDISK PHARMA (SINGAPORE) PTE LTD?
One shareholder is currently on record for NOVO NORDISK PHARMA (SINGAPORE) PTE LTD, held on the electronic register of members filed via BizFile, filed under the Companies Act 1967. The largest of these is NOVO NORDISK REGION AAMEO AND LATAM A/S, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for NOVO NORDISK PHARMA (SINGAPORE) PTE LTD is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does NOVO NORDISK PHARMA (SINGAPORE) PTE LTD have on record?
1 shareholder is shown on record for NOVO NORDISK PHARMA (SINGAPORE) PTE LTD.
What is NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's company registration number?
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's registration number is 199703791E, filed with Accounting and Corporate Regulatory Authority (ACRA) in Singapore. Its current status on the register is active.
Is NOVO NORDISK PHARMA (SINGAPORE) PTE LTD still an active company?
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's status on Accounting and Corporate Regulatory Authority (ACRA) is listed as active.
When was NOVO NORDISK PHARMA (SINGAPORE) PTE LTD incorporated?
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD was incorporated on 6 December 1996, according to Accounting and Corporate Regulatory Authority (ACRA).
What is NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's registered address?
The registered address on file for NOVO NORDISK PHARMA (SINGAPORE) PTE LTD is SINGAPORE, Singapore.
Who are the officers/directors of NOVO NORDISK PHARMA (SINGAPORE) PTE LTD?
The Director of NOVO NORDISK PHARMA (SINGAPORE) PTE LTD currently on record is ANANDA SHETTY; six of the 41 officer records shown for NOVO NORDISK PHARMA (SINGAPORE) PTE LTD are current appointments, filed with Accounting and Corporate Regulatory Authority (ACRA). The remaining 34 records shown (HENRIK EKELUND, GAN CHENG and 28 others) are former appointments that have since been resigned. Management authority at NOVO NORDISK PHARMA (SINGAPORE) PTE LTD sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does NOVO NORDISK PHARMA (SINGAPORE) PTE LTD have a parent company or subsidiaries?
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD sits 4 levels below its ultimate parent, Novo Nordisk Fonden, registered in Denmark.
Can Zavia monitor changes to NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's ownership over time?
This profile reflects a point-in-time snapshot from Accounting and Corporate Regulatory Authority (ACRA). Zavia's monitoring API can track changes to NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Singapore, so records like NOVO NORDISK PHARMA (SINGAPORE) PTE LTD's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Accounting and Corporate Regulatory Authority (ACRA) and was last synced on 6 October 2026.